Concept information
Preferred term
Tacrine
Type
-
mesh:Descriptor
Definition
- A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
Broader concept
Entry terms
- 1,2,3,4-Tetrahydro-9-acridinamine
- 1,2,3,4-Tetrahydroaminoacridine
- 1684-40-8 (HCl)
- 321-64-2 (Tacrine)
- 4966RNG0BU
- 4VX7YNB537
- 9-Acridinamine, 1,2,3,4-tetrahydro-
- 9-Amino-1,2,3,4-Tetrahydroacridine
- Tetrahydroaminoacridine
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
1684-40-8 (HCl)
-
321-64-2 (Tacrine)
-
4966RNG0BU
-
4VX7YNB537
-
9-Acridinamine, 1,2,3,4-tetrahydro-
URI
http://data.loterre.fr/ark:/67375/JVR-BHV5CLGG-1
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}